D.A. DAVIDSON & CO. TARS — TARSUS PHARMACEUTICALS INC

Ownership history in D.A. DAVIDSON & CO.  ·  3 quarters on record

AI Ownership Summary

D.A. DAVIDSON & CO. reported TARSUS PHARMACEUTICALS INC (TARS) in 3 quarterly 13F filings from 2025 Q4 through 2026 Q2. Peak portfolio weight reached 0.01% in 2025 Q4. The latest visible filing shows TARS at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this TARS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was D.A. DAVIDSON & CO.'s position in TARSUS PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

TARS was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

TARS stock page D.A. DAVIDSON & CO. fund profile D.A. DAVIDSON & CO. full holdings
How D.A. DAVIDSON & CO. held TARS — position size vs. price
% of Fund (quarterly)    TARS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 3 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED — — — 15,966 -927 -5.5% 0.01% $1.0M 2026-07-24 $58.66
2026 Q1 REDUCED 7.3% -12.7% ✅ 16,893 -1,340 -7.3% 0.01% $1.2M 2026-05-05 $65.04
2025 Q4 INITIATED — — — 18,233 — — 0.01% $1.5M 2026-01-29 $65.71

🏢 Other funds also holding TARS

As of 2026 Q2 — sorted by position size

HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.3% PSP Research LLC 0.23% Yorktown Management & Research Co Inc 3Y 7Y 0.19% WASATCH ADVISORS LP 3Y 7Y 0.15% Bayforest Capital Ltd 0.1% FOX RUN MANAGEMENT, L.L.C. 3Y 7Y 0.08% Assenagon Asset Management S.A. 3Y 7Y 0.07% Y-Intercept (Hong Kong) Ltd 3Y 0.07% 1620 INVESTMENT ADVISORS, INC. 3Y 0.07% E. Ohman J:or Asset Management AB 0.07%

FAQ About D.A. DAVIDSON & CO. and TARS

These are the practical questions this page is built to answer before you even open the full history table.

How long has D.A. DAVIDSON & CO. reported owning TARS?

D.A. DAVIDSON & CO. reported TARS across 3 quarterly 13F filings, from 2025 Q4 through 2026 Q2.

What was the largest reported TARS position in D.A. DAVIDSON & CO.'s portfolio?

The largest reported portfolio weight for TARS was 0.01% in 2025 Q4.

What is the latest reported TARS position on this page?

The most recent filing on this page is 2026 Q2, when D.A. DAVIDSON & CO. reported 15,966 shares, equal to 0.01% of portfolio, with an estimated market value of $1.0M.

What does the chart on this TARS ownership page compare?

The chart compares D.A. DAVIDSON & CO.'s quarterly TARS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to D.A. DAVIDSON & CO. Holdings